Urinary Extracellular Vesicle Protein Profiles Discriminate Different Clinical Subgroups of Children with Idiopathic Nephrotic Syndrome.
Idiopatic Nephrotic Syndrome
children
extracellular vesicle
liquid biopsy
protein profile
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
06 Mar 2021
06 Mar 2021
Historique:
received:
29
01
2021
revised:
02
03
2021
accepted:
03
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Idiopathic nephrotic syndrome (INS) is the most frequent primary glomerular disease in children, displaying high grade proteinuria and oedema. The mainstay of therapy are steroids, and patients are usually classified according to the treatment response (sensitive vs. resistant). The mechanisms involved in INS pathogenesis and treatment responsiveness have not yet been identified. In this context, the analysis of urinary extracellular vesicles (UEv) is interesting, since they represent a molecular snapshot of the parental cells, offering a "fingerprint" for monitoring their status. Therefore, the aim of this study is to verify the feasibility of using UEv of INS patients as indicators of therapy response and its prediction. UEv were isolated from the urine of pediatric patients in remission after therapy; they showed characteristic electrophoresis profiles that matched specific patient subgroups. We then built a statistical model to interpret objectively each patient UEv protein profile: in particular, steroid-resistant patients cluster together with a very distinct pattern from other INS patients and controls. In conclusion, the evaluation of the UEv protein profile looks promising in the investigation of INS, showing a disease signature that might predict clinical evolution.
Identifiants
pubmed: 33800879
pii: diagnostics11030456
doi: 10.3390/diagnostics11030456
pmc: PMC7998527
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Department of Clinical Sciences and Community Health (DISCCO), Univesrity of Milan
ID : Piano di sviluppo alla ricerca 2017
Références
Eur J Clin Pharmacol. 2019 Dec;75(12):1675-1683
pubmed: 31463578
Ital J Pediatr. 2017 Apr 21;43(1):41
pubmed: 28427453
Clin J Am Soc Nephrol. 2010 Nov;5(11):2115-21
pubmed: 20966123
Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1251-9
pubmed: 24694589
Lancet. 2018 Jul 7;392(10141):61-74
pubmed: 29910038
Proteomics. 2013 May;13(10-11):1572-80
pubmed: 23129434
Nephrol Dial Transplant. 2015 Apr;30(4):621-30
pubmed: 25422309
Proteomics. 2011 Feb;11(4):709-20
pubmed: 21241021
Mol Biosyst. 2013 Jun;9(6):1220-33
pubmed: 23511837
Kidney Int. 2010 Oct;78(8):810-6
pubmed: 20686450
J Extracell Vesicles. 2020 Mar 11;9(1):1736935
pubmed: 32284825
Mass Spectrom Rev. 2011 Nov-Dec;30(6):1185-202
pubmed: 21544848
Cell Stress Chaperones. 2018 Sep;23(5):943-953
pubmed: 29796787
Pediatr Nephrol. 2018 Apr;33(4):573-584
pubmed: 28451893
Pediatr Nephrol. 2012 Feb;27(2):317-20
pubmed: 22076591
EBioMedicine. 2019 Jul;45:351-361
pubmed: 31229437
Pediatr Res. 2017 Jan;81(1-2):233-239
pubmed: 27682967
Expert Rev Proteomics. 2016;13(3):309-24
pubmed: 26698090
Front Immunol. 2018 Dec 13;9:2723
pubmed: 30619239
Crit Rev Clin Lab Sci. 2020 Aug;57(5):345-364
pubmed: 32058809
EBioMedicine. 2019 Jan;39:552-561
pubmed: 30467011
Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F553-9
pubmed: 23761678
Nat Rev Nephrol. 2019 Dec;15(12):750-765
pubmed: 31654044
Acta Physiol (Oxf). 2020 Jan;228(1):e13346
pubmed: 31334916
Biomed Res Int. 2021 Jan 11;2021:6611244
pubmed: 33506022
J Nephrol. 2020 Aug;33(4):849-857
pubmed: 31617157